Nomura Asset Management CO LTD Biogen Inc. Transaction History

Nomura Asset Management CO LTD

$28.9 Billion
Q2 2024

A detailed history of Nomura Asset Management CO LTD transactions in Biogen Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 56,093 shares of BIIB stock, worth $10.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

56,093

Previous 70,044 19.92%

Holding current value

$10.9 Million

Previous $15.1 Million 13.9%

% of portfolio

0.04%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $2.66 Million - $3.3 Million	-13,951 Reduced 19.92%	56,093 $13 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $350,045 - $441,989	-1,651 Reduced 2.3%	70,044 $15.1 Million
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $332,772 - $400,570	1,495 Added 2.13%	71,695 $18.6 Million
Q3 2023 Nov 03, 2023	SELL	$253.3 - $285.89 $2 Million - $2.25 Million	-7,882 Reduced 10.09%	70,200 $18 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $4.63 Million - $5.35 Million	16,835 Added 27.49%	78,082 $22.2 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $57,469 - $65,484	-224 Reduced 0.36%	61,247 $17 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $5.22 Million - $6.34 Million	20,683 Added 50.71%	61,471 $17 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $326,689 - $450,475	-1,678 Reduced 3.95%	40,788 $10.9 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $500,356 - $595,017	2,668 Added 6.7%	42,466 $8.66 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $309,644 - $390,135	-1,598 Reduced 3.86%	39,798 $8.38 Million
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $1.76 Million - $2.26 Million	-7,843 Reduced 15.93%	41,396 $9.93 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $1.28 Million - $1.67 Million	-4,522 Reduced 8.41%	49,239 $13.9 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $24.4 Million - $39.1 Million	-94,274 Reduced 63.68%	53,761 $18.6 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1.05 Million - $1.23 Million	4,320 Added 3.01%	148,035 $41.4 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $1.12 Million - $1.69 Million	-4,749 Reduced 3.2%	143,715 $35.2 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $328,050 - $378,774	-1,239 Reduced 0.83%	148,464 $42.1 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $21.2 Million - $28.1 Million	82,136 Added 121.56%	149,703 $40.1 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $716,485 - $908,871	2,665 Added 4.11%	67,567 $21.4 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $834,027 - $1.15 Million	3,790 Added 6.2%	64,902 $19.3 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $236,139 - $264,853	-1,086 Reduced 1.75%	61,112 $14.2 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $582,872 - $642,491	2,658 Added 4.46%	62,198 $14.5 Million
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $17.4 Million - $27.2 Million	-80,147 Reduced 57.38%	59,540 $14.1 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $23.3 Million - $29.5 Million	-83,747 Reduced 37.48%	139,687 $42 Million
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $2.24 Million - $2.93 Million	-7,637 Reduced 3.31%	223,434 $78.9 Million
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $713,330 - $850,140	-2,770 Reduced 1.18%	231,071 $67.1 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $2.01 Million - $2.84 Million	7,721 Added 3.41%	233,841 $64 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $9.73 Million - $10.9 Million	31,644 Added 16.27%	226,120 $72 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $36.1 Million - $42.3 Million	128,450 Added 194.54%	194,476 $60.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	66,026	66,026 $17.9 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Biogen Inc. Transaction History